What are you looking for today?

Alam, Muhammad Irfan, Paget, Timothy, Moosa, Najla Yussuf, Alghurairy, Husein and Elkordy, Amal (2024) Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy. Pharmaceutics, 16 (9). ISSN 1999-4923

Document

Abstract

Abstract

Helicobacter pylori (H. pylori) infection is a significant global health concern, affecting approximately 50% of the world’s population and leading to gastric ulcers, gastritis, and gastric cancer. The increase in antibiotic resistance has compromised the efficacy of existing therapeutic regimens, necessitating novel approaches for effective eradication. This study aimed to develop a targeted liposomal drug delivery system incorporating furazolidone and N-acetylcysteine (NAC) to enhance mucopenetration and improve Helicobacter pylori eradication. Liposomes were formulated with furazolidone, NAC, and Pluronic F-127 using a modified reverse-phase evaporation technique. The formulations were categorized based on charge as neutral, negative, and positive and tested for mucopenetration using a modified silicon tube method with coumarin-6 as a fluorescent marker. The encapsulation efficiency and particle size were analyzed using HPLC and an Izon q-nano particle size analyzer. The results indicated that charged liposomes showed a higher encapsulation efficiency than neutral liposomes with Pluronic F-127. Notably, combining furazolidone with 1% NAC achieved complete eradication of H. pylori in 2.5 h, compared to six hours without NAC. The findings of this study suggest that incorporating NAC and Pluronic F-127 into liposomal formulations significantly enhances mucopenetration and antimicrobial efficacy.

Item Type: Article
Uncontrolled Keywords: mucus penetration; liposomes; N-acetyl cysteine; H. pylori; furazolidone; augmented therapy
Depositing User: Amal Elkordy
URI: https://sure.sunderland.ac.uk/id/eprint/18017

Further Details

More Information

Uncontrolled Keywords
mucus penetration; liposomes; N-acetyl cysteine; H. pylori; furazolidone; augmented therapy
Depositing User

Identifiers

Item ID
18017
Identification Number
ISSN
1999-4923

Users with ORCIDS

ORCID for Timothy Paget
ORCID for Najla Yussuf Moosa
ORCID for Amal Elkordy

Catalogue record

Date Deposited
09 Sep 2024 13:47
Last Modified
26 Nov 2025 09:09

Contributors

Author
Muhammad Irfan Alam
Author
Husein Alghurairy

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year